Category Archives: Cancer Treatment

The NFL And Cancer Treatment Centers Of America Combine Their Efforts For Prostate Cancer Awareness

More than 160,000 men aged 40 or older will be diagnosed with prostate cancer in the U.S. in 2017, a number which has prompted the National Football League Alumni, LabCorp, and The Cancer Treatment Centers of America to partner for Prostate Cancer Awareness Month. The aim of the month is to educate men in the target range of 40 or older about the dangers of the most common form of cancer seen among men.

The Cancer Treatment Centers of America and LabCorp have come together to bring a number of free and discounted prostate cancer screenings to men who meet eligibility requirements. The majority of men over 40 are recommended to undertake the Prostate Specific Antigen test which can provide a guide to physicians about the possibility of prostate cancer being found within the body of an individual patient; The Cancer Treatment Centers of America believe it important to advise patients that a positive result from the PSA is not a guarantee of prostate cancer being present.

Alongside the offer of free and discounted PSA screenings, The Cancer Treatment Centers of America is also working to raise awareness of prostate cancer with the NFL. During regular season football games during Prostate Cancer Awareness Month, a number of public service announcements will be screened featuring iconic former NFL coaches.

Founded in 1988, The Cancer Treatment Centers of America was founded by Robert J. Stephenson after the death of his own mother from cancer. Stephenson felt a better approach could be found to research and treat different forms of cancer that were available during his mother’s illness.

The use of various complimentary-therapies marks the difference between The Cancer Treatment Centers of America and other healthcare providers who do not provide nutritional and alternative therapies to aid in recovery from traditional cancer treatments.

To Learn More : http://www.myctca.com

Eric Lefkofsky Participates in Fight for Cancer

As the year’s pass, cost of health care has been increasing. Patients intense demands, and costly attention have contributed to the higher medical care. As reported in JAMA, growth in population and getting aged can as well result in the spending cost. According to Joseph Dieleman, the study leader, medical costs for different diseases depend on various factors.

For instance, during the period of study, diabetes recorded the most significant increase of $ 64 billion annually with $40 billion spend on medication. Each factor analyzed has an impact on the increased medical care charges. Dieleman, mentioned aging, pharmaceuticals usage, diabetes prevalence and population growth as some of the cost factors in the US healthcare upsurge.

Neck pain and low back recorded an increase of 8.5% for the inpatient care, with an annual spending of $57 billion. Regardless of reduction in medical expenditure summing up to $201 billion, the inpatient cost for all illnesses increased by $439 billion from $258 billion per annum. The efforts to reduce medical spending has not fully impacted as projected.

According to the director of Centre for Health Policy Peter Bach, pharmaceuticals are not a significant reduction of cost. The costly drugs, prescribed to patients to prevent hospitalization, is not a crucial factor in medical care spending. Cost breakdown would aid researchers in analyzing the specific spending factors.

Eric Lefkofsky

Born on 1969 September 2nd and an American businessman, Eric is a co-founder of Tempus. He chairs the technology company known to be at the forefront in fighting cancer. The entrepreneur traded carpets at the University of Michigan. In collaboration with his colleague Brad Keywell, they co-founded Brandon Apparel after the completion of law school. They later founded Echo Global Logistics, in 2005 a freight and logistics business. Eric invented Starbelly, a technology company that aimed at products advertisement.

Eric Lefkofsky is an investor who has participated in the formation of Mediaocean, Inner Workings, Uptake technologies, and LightBank. He launched a family Foundation in 2016, that is aimed at supporting educational, scientific charitable institutions. The focus of this foundation is on children and has offered support to over 50 organizations. The charity center is under the management of Lefkofsky family.

Read More : www.tempus.com/about-us/

Clay Siegall and his Contributions in Cancer Treatment

Clay Siegall is a skilled biotechnology expert who is impacting lives of cancer patients all over the world. Clay is the profound founder of Seattle Genetics, which is a biotechnology established in the year 1998 and it has since instituted many cancer therapies. The company made debut in the cancer treatment industry when it created Adcetris, which is already being utilized in the market. In a recent report, the Adcetris drug has successfully managed to cure over 15,000 lymphoma cases in the world.

Currently, Clay Siegall serves as both the president and chief executive officer at Seattle Genetics. He additionally serves as the chair to the board of directors. Under his leadership tenure, Seattle Genetics has been working hard to establish an extensive portfolio, which could address preclinical and clinical products that could treat the different forms of cancers as well as other autoimmune illnesses affecting today’s people.

Seattle Genetics is presently regarded as one of the leaders in the United States’ antibody technologies, in particular in the division of antibody-drug conjugate. The firm’s success is attributable to the skills and experience of their CEO and president, Clay Siegall. The renowned biotechnology expert has also been pioneering the capital raising procedures of the Seattle Genetics firm. In a recent report, Clay Siegall is considered to have aided the company in raising more than hundred million in both public and private financing

The Clay Siegall-raised capital will be utilized in developing safer and better drugs for treating the prevalent cancers affecting today’s society. According to Siegall, Seattle Genetics will begin introducing treatment drugs for breast cancer soon. The firm has additionally released a report, which stated that it aims at adding the number of its workforce for facilitating the development of new drugs. Before he founded Seattle Genetics, Clay Siegall was deeply into the biotechnology sector. He once worked with the renowned Bristol-Myers, which is among the most famous firms in the US. He has additionally served at the National Cancer Institute. Through his skills and experience in the sector, Clay Siegall has been of positive impact in every position he has held in the various entities he has worked with. Clay Siegall is also an outside director of the Mirna Therapeutics board of directors.